Evidence map›Paper›PMID 37957094›Full record

ReviewDifferentiation; research in biological diversity

FGF5.

Evelyn A Carrion, Malcolm M Moses, Richard R Behringer

Open access · greenAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Differentiation; research in biological diversity. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Dachshund spinal health by coat and size type.Journal of veterinary internal medicine · 2026
    Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Evelyn A CarrionDepartment of Genetics, University of Texas MD Anderson Cancer Center, Houston, TX, 77030, United States.
Malcolm M MosesDepartment of Genetics, University of Texas MD Anderson Cancer Center, Houston, TX, 77030, United States.
Richard R BehringerDepartment of Genetics, University of Texas MD Anderson Cancer Center, Houston, TX, 77030, United States. Electronic address: rrb@mdanderson.org.
The University of Texas MD Anderson Cancer Center · US

Funding

Molecular Genetics of Female Reproductive TractR01HD030284 · NICHD · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI BEHRINGER, RICHARD R · 1994 to 2013
$4.5M
Female Reproductive Tract Development in the MouseR37HD030284 · NICHD · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI BEHRINGER, RICHARD R · 2014 to 2023
$4.2M
Gene Regulatory Networks for Mullerian Duct RegressionF31HD106600 · NICHD · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI MOSES, MALCOLM MAURIECE · 2021 to 2022
$63k
NICHD NIH HHS F31 HD106600NICHD NIH HHS R01 HD030284NICHD NIH HHS R37 HD030284
6 · The paper itself

Abstract

FGF5 functions as a negative regulator of the hair cycle in mammals. It is expressed in the outer root sheath of hair follicles during the late anagen phase of the hair cycle. It functions as a signaling molecule, mediating the transition of the anagen growth phase to catagen regression phase of the hair cycle. Spontaneous and engineered FGF5 mutations in mammalian animal models result in long hair phenotypes. In humans, inherited FGF5 mutations result in trichomegaly (long eyelashes). Knockdown of fgf5 in zebrafish embryos results in inner ear alterations. Alterations in FGF5 expression are also associated with various human pathologies.

Indexed as

Fibroblast Growth Factor 5ZebrafishAnimalsHairHair FollicleHumansMutationSignal TransductionFibroblast Growth Factor 5AngoraHair cycleInner earTrichomegaly

Identifiers

PMID37957094
PMCPMC12535173
OpenAlexW4388460039

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.